Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Avicanna Inc T.AVCN

Alternate Symbol(s):  AVCNF

Avicanna Inc. is a Canada-based commercial-stage international biopharmaceutical company. The Company's scientific platform commercializes over thirty products across various market segments: Medical Cannabis formulary (RHO Phyto), Medical cannabis care platform (MyMedi.ca), Pharmaceutical pipeline, and Active pharmaceutical ingredients (Aureus Santa Marta). RHO Phyto formulary offers a diverse... see more

TSX:AVCN - Post Discussion

Avicanna Inc > 2 new SKU's
View:
Post by amishelvis on Aug 27, 2024 6:01pm

2 new SKU's

I'm on the Avicanna email list and about 5 days ago i got one from them saying they just added two new items for sale. it's the pill/ capsule form for fast relief. They were just awarded the patent for that a few months ago, and i was happy to see them turn around and make a product so fast. I was surprised that it wasnt a news release though.
Comment by amishelvis on Aug 27, 2024 6:05pm
Here is the meat of it... Avicanna is thrilled to announce that our proprietary SEDDs technology based capsules have officially launched with their global debut on the MyMedi.caplatform. Patients will now have access to these single dose, rapid acting capsules with enhanced absorption.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities